The involvement of MMP-9 in inflammatory diseases, such as its high plasma levels in COVID-19 patients from our study, was also supported by our previous demonstration that the plasma MMP-9 level was significantly higher in patients with community-acquired pneumonia compared with that in control subjects [61]. This evidence concerns the gene MMP9 and COVID-19.